An Explorative Randomized Controlled Investigation Evaluating Newly Developed Ostomy Products

NCT ID: NCT02351817

Last Updated: 2016-01-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the investigation is to explore the acceptance of a newly developed adhesive.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Baseline - Test A - Test B

Three period investigation. First each subject tests baseline product, then Test A and finally Test B.

Baseline product: the subject's usual product

Test A: A newly developed 1-piece, open ostomy appliance for collecting feces

Test B: A newly developed 1-piece, open ostomy appliance for collecting feces

Group Type EXPERIMENTAL

Test A

Intervention Type DEVICE

Ostomy appliance

Test B

Intervention Type DEVICE

Ostomy appliance

Baseline

Intervention Type DEVICE

Ostomy appliance

Baseline - Test B - Test A

First each subject tests baseline product, then Test B and finally Test A.

Baseline product: the subject's usual product

Test A: A newly developed 1-piece, open ostomy appliance for collecting feces

Test B: A newly developed 1-piece, open ostomy appliance for collecting feces

Group Type EXPERIMENTAL

Test A

Intervention Type DEVICE

Ostomy appliance

Test B

Intervention Type DEVICE

Ostomy appliance

Baseline

Intervention Type DEVICE

Ostomy appliance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test A

Ostomy appliance

Intervention Type DEVICE

Test B

Ostomy appliance

Intervention Type DEVICE

Baseline

Ostomy appliance

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have given written informed consent and letter of authority
* Be at least 18 years of age and have full legal capacity
* Be able to handle the products her/himself
* Have an ileostomy with a diameter between 10 and 30 mm
* Willing to follow the product change schedule (one change per day)
* Have had their ostomy for at least three months
* Willing to use 1 piece open ostomy products during the test period
* Must be able to use a custom cut product
* Have intact skin
* Negative result of a pregnancy test for women of childbearing age

Exclusion Criteria

* Currently receiving or have within the past 2 months received radio- and/or chemotherapy
* Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/ injection) treatment
* Is pregnant or breastfeeding.
* Is participating in other interventional clinical investigations or have previously participated in this investigation
* Have a loop ileostomy
* Known hypersensitivity towards any of the test products
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Birte Petersen Jakobsen, MD

Role: PRINCIPAL_INVESTIGATOR

Coloplast A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coloplast A/S

Humlebæk, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP256

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP376 OCT Exploratory Skin Study
NCT06965140 COMPLETED NA
Feasibility Study of a New Fistula Pouching System
NCT00294450 COMPLETED PHASE2/PHASE3